Sorrento Therapeutics, Inc. (SRNE)

Sorrento Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jun 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	69.75	23.63	36.67	56.46	22.52	158.74
Short-Term Investments	10.89	26.34	90.22	-	-	-
Cash & Short-Term Investments	80.64	49.98	126.88	56.46	22.52	158.74
Cash Growth	-39.65%	-60.61%	124.71%	150.72%	-85.81%	660.60%
Accounts Receivable	32.73	24.47	18.72	15.51	14.45	3.83
Other Receivables	-	-	-	-	-	0.53
Receivables	32.73	24.47	18.72	15.51	14.45	4.36
Inventory	9.65	9.98	8.11	1.83	3.36	2.9
Prepaid Expenses	5.22	8.81	11.8	8.71	11.75	3.98
Restricted Cash	-	-	-	-	13.1	9.59
Other Current Assets	4.88	3.14	7.48	3.72	2.4	-
Total Current Assets	133.11	96.37	172.99	86.23	67.59	179.56
Property, Plant & Equipment	106.65	138.44	126.5	73.91	76.27	24.38
Long-Term Investments	12.01	17.18	51.27	256.4	262.24	264.99
Goodwill	80.27	80.27	79.53	43.55	38.3	38.3
Other Intangible Assets	122.28	136.9	259.71	73.68	63.31	66.28
Other Long-Term Assets	2.38	3.69	4.83	2.05	49.93	50.57
Total Assets	456.69	472.84	694.82	535.82	557.63	624.09
Accounts Payable	74.63	47.52	27.41	24.71	27.63	13.82
Accrued Expenses	101.43	66.64	59.48	40.06	34.64	23.64
Current Portion of Long-Term Debt	45.36	16.29	31.98	23.21	36.26	10.15
Current Portion of Leases	13.05	13.88	11.54	3.63	3.32	-
Current Unearned Revenue	0.26	0.65	1.11	4.49	3.64	2.7
Other Current Liabilities	6.21	182.95	7.93	0.4	9.71	11.31
Total Current Liabilities	328.87	327.92	139.45	96.48	115.21	61.62
Long-Term Debt	21.74	19.13	110.63	92.26	199.09	223.14
Long-Term Leases	52.45	85.21	83.43	50.3	52.11	-
Long-Term Unearned Revenue	7.86	7.1	118.94	113.19	114.39	116.27
Long-Term Deferred Tax Liabilities	0.24	0.59	2.43	6.92	9.04	9.42
Other Long-Term Liabilities	243.5	54.56	161.81	35.95	35.04	6.14
Total Liabilities	654.65	494.51	616.69	395.09	524.88	416.59
Common Stock	0.06	0.05	0.03	0.03	0.02	0.01
Additional Paid-In Capital	2,036	1,989	1,514	1,172	788.12	626.66
Retained Earnings	-2,194	-1,959	-1,387	-958.28	-659.82	-367.75
Treasury Stock	-49.46	-49.46	-49.46	-49.46	-49.46	-49.46
Comprensive Income & Other	2.24	1.5	1.03	0.52	-0.27	0.02
Total Common Equity	-205.11	-18.61	78.75	165.15	78.59	209.47
Minority Interest	7.16	-3.06	-0.62	-24.42	-45.83	-1.97
Shareholders' Equity	-197.96	-21.67	78.13	140.73	32.76	207.5
Total Liabilities & Equity	456.69	472.84	694.82	535.82	557.63	624.09
Total Debt	207.6	134.5	237.58	169.39	290.78	233.29
Net Cash (Debt)	-126.97	-84.53	-110.7	-112.93	-268.26	-74.55
Net Cash Per Share	-0.25	-0.20	-0.38	-0.49	-1.91	-0.70
Filing Date Shares Outstanding	543.71	543.71	334.77	272.75	173.77	114.71
Total Common Shares Outstanding	543.71	515.25	307.01	267.72	160.23	114.71
Working Capital	-195.76	-231.55	33.54	-10.25	-47.62	117.94
Book Value Per Share	-0.38	-0.04	0.26	0.62	0.49	1.83
Tangible Book Value	-407.67	-235.78	-260.48	47.92	-23.02	104.89
Tangible Book Value Per Share	-0.75	-0.46	-0.85	0.18	-0.14	0.91
Machinery	-	68.91	61.31	43.55	35.21	29.45
Construction In Progress	-	18.23	7.88	4.03	3.86	1.22
Leasehold Improvements	-	16.16	15.53	14.3	13.16	9

Source: S&P Capital IQ. Standard template. Financial Sources.